Brian K Flesner

11PUBLICATIONS
56CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 07, 2026
Near-Infrared Imaging Using a Cathepsin-Targeted, Quenched Activity-Based Probe Identifies Naturally Occurring Canine Appendicular Osteosarcoma.

Anna M Massie, Charles W Bradley, Wilfried Mai

|Jul 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs.

Amy K LeBlanc, Christina N Mazcko, Timothy M Fan

|Apr 26, 2022
Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study.

Andi Flory, Kristina M Kruglyak, John A Tynan

|Mar 09, 2022
Fracture rate and time to fracture in dogs with appendicular osteosarcoma receiving finely fractionated compared to coarsely fractionated radiation therapy: A single institution study.

Carissa J Norquest, Charles A Maitz, Deborah A Keys

|Nov 26, 2021
Toxicity, outcome, and management of anthracycline overdoses in 16 dogs.

Haylie C Lawson, Margaret L Musser, Rebecca Regan

|Mar 23, 2021
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.

Amy K LeBlanc, Christina N Mazcko, Aswini Cherukuri

Pageof 2

Frequent Collaborators

3 joint publications

Jeffrey N Bryan

2 joint publications

David M Vail

2 joint publications

Carolyn J Henry

1 joint publications

James H Doroshow